Strategic Wealth Advisors Group LLC trimmed its stake in Omega Healthcare Investors Inc (NYSE:OHI) by 7.5% in the 3rd quarter, HoldingsChannel reports. The fund owned 16,306 shares of the real estate investment trust’s stock after selling 1,331 shares during the quarter. Strategic Wealth Advisors Group LLC’s holdings in Omega Healthcare Investors were worth $674,000 as of its most recent SEC filing.
Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Krane Funds Advisors LLC purchased a new position in Omega Healthcare Investors during the 2nd quarter worth $25,000. Coastal Investment Advisors Inc. grew its stake in Omega Healthcare Investors by 148.4% during the 2nd quarter. Coastal Investment Advisors Inc. now owns 683 shares of the real estate investment trust’s stock worth $26,000 after buying an additional 408 shares during the last quarter. Redhawk Wealth Advisors Inc. purchased a new position in Omega Healthcare Investors during the 2nd quarter worth $31,000. Phocas Financial Corp. purchased a new position in Omega Healthcare Investors during the 2nd quarter worth $32,000. Finally, Kavar Capital Partners LLC purchased a new position in Omega Healthcare Investors during the 2nd quarter worth $33,000. 69.27% of the stock is owned by hedge funds and other institutional investors.
In other news, CFO Robert O. Stephenson sold 10,000 shares of the company’s stock in a transaction dated Friday, August 16th. The stock was sold at an average price of $39.00, for a total value of $390,000.00. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. Also, CAO Michael Ritz sold 2,500 shares of the company’s stock in a transaction dated Wednesday, September 25th. The stock was sold at an average price of $42.00, for a total value of $105,000.00. Following the completion of the sale, the chief accounting officer now owns 5,485 shares in the company, valued at approximately $230,370. The disclosure for this sale can be found here. In the last quarter, insiders have sold 45,500 shares of company stock worth $1,822,300. Company insiders own 1.16% of the company’s stock.
Omega Healthcare Investors stock traded down $0.16 during trading hours on Friday, hitting $41.07. 2,547,785 shares of the stock traded hands, compared to its average volume of 1,675,720. The company has a debt-to-equity ratio of 1.17, a current ratio of 2.78 and a quick ratio of 2.78. The firm’s 50 day moving average price is $42.82 and its 200-day moving average price is $38.90. The stock has a market capitalization of $9.25 billion, a price-to-earnings ratio of 13.51, a P/E/G ratio of 5.76 and a beta of 0.33. Omega Healthcare Investors Inc has a 1 year low of $33.39 and a 1 year high of $45.01.
Omega Healthcare Investors (NYSE:OHI) last posted its quarterly earnings results on Tuesday, November 5th. The real estate investment trust reported $0.63 earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of $0.73 by ($0.10). The firm had revenue of $199.00 million for the quarter, compared to analysts’ expectations of $194.26 million. Omega Healthcare Investors had a net margin of 38.12% and a return on equity of 8.87%. The firm’s revenue for the quarter was up 3.5% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.77 EPS. Research analysts forecast that Omega Healthcare Investors Inc will post 2.95 earnings per share for the current fiscal year.
The company also recently declared a quarterly dividend, which will be paid on Friday, November 15th. Shareholders of record on Thursday, October 31st will be paid a dividend of $0.67 per share. This represents a $2.68 annualized dividend and a yield of 6.53%. The ex-dividend date of this dividend is Wednesday, October 30th. This is an increase from Omega Healthcare Investors’s previous quarterly dividend of $0.66. Omega Healthcare Investors’s payout ratio is presently 88.16%.
Several research analysts recently weighed in on the company. Raymond James downgraded Omega Healthcare Investors from a “strong-buy” rating to a “market perform” rating in a research note on Monday, October 21st. Zacks Investment Research downgraded Omega Healthcare Investors from a “hold” rating to a “sell” rating in a research note on Wednesday. Bank of America restated a “buy” rating and set a $44.50 target price on shares of Omega Healthcare Investors in a research note on Monday, October 14th. Berenberg Bank assumed coverage on Omega Healthcare Investors in a research note on Thursday, September 12th. They set a “buy” rating and a $47.00 price target on the stock. Finally, Wells Fargo & Co boosted their price target on Omega Healthcare Investors from $36.00 to $40.00 and gave the company a “market perform” rating in a research note on Friday, August 23rd. One research analyst has rated the stock with a sell rating, five have given a hold rating and three have issued a buy rating to the company. Omega Healthcare Investors has an average rating of “Hold” and a consensus price target of $41.98.
About Omega Healthcare Investors
Omega is a real estate investment trust that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the US, as well as in the UK.
Featured Article: Most Volatile Stocks – What Investors Need to Know to Maximize ROI
Want to see what other hedge funds are holding OHI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Omega Healthcare Investors Inc (NYSE:OHI).